KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) Equity Average (2016 - 2025)

Merck (MRK) has disclosed Equity Average for 17 consecutive years, with $50.5 billion as the latest value for Q3 2025.

  • On a quarterly basis, Equity Average rose 14.46% to $50.5 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $50.5 billion, a 14.46% increase, with the full-year FY2024 number at $42.0 billion, changed 0.38% from a year prior.
  • Equity Average was $50.5 billion for Q3 2025 at Merck, up from $48.7 billion in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $50.5 billion in Q3 2025 to a low of $26.2 billion in Q1 2021.
  • A 5-year average of $41.3 billion and a median of $42.1 billion in 2022 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: skyrocketed 51.04% in 2022, then fell 16.03% in 2024.
  • Merck's Equity Average stood at $37.1 billion in 2021, then increased by 22.21% to $45.3 billion in 2022, then dropped by 12.86% to $39.5 billion in 2023, then rose by 15.2% to $45.5 billion in 2024, then rose by 11.04% to $50.5 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Equity Average are $50.5 billion (Q3 2025), $48.7 billion (Q2 2025), and $47.4 billion (Q1 2025).